HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kai Li Selected Research

histocompatibility antigen 37

9/2017MGr1-Antigen/37 kDa laminin receptor precursor promotes cellular prion protein induced multi-drug-resistance of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kai Li Research Topics

Disease

345Neoplasms (Cancer)
10/2022 - 08/2003
64Infections
03/2022 - 10/2011
54Breast Neoplasms (Breast Cancer)
05/2022 - 07/2009
53Neoplasm Metastasis (Metastasis)
06/2022 - 01/2006
49Stomach Neoplasms (Stomach Cancer)
05/2022 - 02/2009
40Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 08/2005
35Hepatocellular Carcinoma (Hepatoma)
03/2022 - 09/2008
35Carcinogenesis
03/2022 - 08/2003
35Inflammation (Inflammations)
01/2022 - 12/2007
30Vitiligo
01/2022 - 03/2009
22Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 06/2008
21Adenocarcinoma of Lung
03/2022 - 04/2008
21Carcinoma (Carcinomatosis)
01/2022 - 06/2008
20Parkinson Disease (Parkinson's Disease)
07/2022 - 03/2011
20Lung Neoplasms (Lung Cancer)
01/2022 - 03/2006
19Fibrosis (Cirrhosis)
06/2022 - 01/2016
19Lymphatic Metastasis
01/2022 - 09/2009
16Virus Diseases (Viral Diseases)
09/2022 - 11/2006
16Prostatic Neoplasms (Prostate Cancer)
07/2022 - 11/2010
16Wounds and Injuries (Trauma)
06/2022 - 01/2004
16Osteoporosis
03/2022 - 12/2011
16Hemorrhage
01/2022 - 11/2006
14Hypoxia (Hypoxemia)
07/2022 - 01/2006
12Hypertension (High Blood Pressure)
10/2022 - 01/2017
12Marek Disease (Marek's Disease)
09/2022 - 11/2016
12Urinary Bladder Neoplasms (Bladder Cancer)
06/2022 - 07/2013
12Obesity
02/2022 - 01/2015
12Pain (Aches)
01/2022 - 04/2010
12Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2006
11Kaposiform Hemangioendothelioma
07/2022 - 08/2014
11Glioma (Gliomas)
01/2022 - 05/2013
11Neuroblastoma
01/2021 - 12/2009
11Insulin Resistance
01/2020 - 09/2013
10Body Weight (Weight, Body)
12/2021 - 11/2006
9Disease Progression
10/2022 - 09/2008
9Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2022 - 06/2013
9Necrosis
02/2022 - 01/2015
9Glioblastoma (Glioblastoma Multiforme)
01/2022 - 02/2010
9Ischemia
04/2021 - 01/2014
8Adenocarcinoma
08/2022 - 12/2012
8Hepatic Encephalopathy
05/2022 - 07/2012
8Neuralgia (Stump Neuralgia)
02/2022 - 10/2012
8Ascites
01/2022 - 06/2011
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 12/2011
8Reperfusion Injury
11/2021 - 01/2015
8Tuberous Sclerosis (Bourneville's Disease)
01/2021 - 01/2016
8Type 2 Diabetes Mellitus (MODY)
10/2020 - 11/2012

Drug/Important Bio-Agent (IBA)

107Proteins (Proteins, Gene)FDA Link
07/2022 - 07/2002
44Biomarkers (Surrogate Marker)IBA
07/2022 - 04/2010
41Biological ProductsIBA
05/2022 - 08/2003
37Pharmaceutical PreparationsIBA
03/2022 - 02/2009
32MicroRNAs (MicroRNA)IBA
06/2022 - 02/2010
32Messenger RNA (mRNA)IBA
01/2022 - 01/2004
27VaccinesIBA
09/2022 - 09/2008
25DNA (Deoxyribonucleic Acid)IBA
09/2021 - 10/2005
24CytokinesIBA
11/2021 - 05/2011
23RNA (Ribonucleic Acid)IBA
05/2022 - 01/2015
23EnzymesIBA
05/2022 - 01/2009
22anlotinibIBA
10/2022 - 01/2018
20Long Noncoding RNAIBA
03/2022 - 01/2014
19ErbB Receptors (EGF Receptor)IBA
01/2022 - 03/2006
18Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 11/2010
16CateninsIBA
02/2022 - 12/2013
16Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2014
15Therapeutic UsesIBA
01/2022 - 10/2009
14Antiviral Agents (Antivirals)IBA
09/2022 - 09/2008
14Cisplatin (Platino)FDA LinkGeneric
06/2022 - 08/2005
14PolymersIBA
01/2022 - 03/2011
14Small Interfering RNA (siRNA)IBA
04/2019 - 11/2007
13Indicators and Reagents (Reagents)IBA
12/2022 - 06/2010
13Peptides (Polypeptides)IBA
10/2021 - 01/2008
12Sirolimus (Rapamycin)FDA Link
07/2022 - 01/2015
126-methyladenineIBA
05/2022 - 01/2020
12Folic Acid (Vitamin M)FDA LinkGeneric
03/2022 - 01/2010
12Hormones (Hormone)IBA
02/2022 - 03/2005
12AntioxidantsIBA
06/2021 - 07/2012
11Circular RNAIBA
06/2022 - 01/2018
11Phosphotransferases (Kinase)IBA
01/2022 - 02/2013
11AntigensIBA
10/2021 - 06/2008
11EndostatinsIBA
06/2019 - 08/2005
10Transcription Factors (Transcription Factor)IBA
03/2022 - 03/2005
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 04/2008
9AlbuminsIBA
01/2022 - 01/2004
9UbiquitinIBA
01/2022 - 01/2018
9Cell-Free Nucleic AcidsIBA
01/2021 - 01/2015
8Tyrosine Kinase InhibitorsIBA
01/2022 - 08/2007
8Doxorubicin (Adriamycin)FDA LinkGeneric
08/2021 - 02/2009
8InterferonsIBA
10/2020 - 02/2017

Therapy/Procedure

125Therapeutics
10/2022 - 09/2008
45Drug Therapy (Chemotherapy)
10/2022 - 08/2005
19Immunotherapy
10/2022 - 12/2011
17Radiotherapy
06/2022 - 06/2012
13Transjugular Intrahepatic Portasystemic Shunt
05/2022 - 09/2017
12Surgical Portasystemic Shunt (Portosystemic Shunt)
05/2022 - 09/2017
12Lasers (Laser)
03/2022 - 11/2012
11Precision Medicine
01/2021 - 01/2017
11Gastrectomy
11/2020 - 08/2010
10Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2021 - 07/2012
9Lymph Node Excision (Lymph Node Dissection)
01/2022 - 11/2009
8Neoadjuvant Therapy
06/2022 - 01/2014